Biosimilar medicines – Recent regulatory developments in the European Union and France

What is a biosimilar product? A biosimilar is a biological medicine (i.e., a medicine whose active substance is made by a living organism) highly similar to another already approved biological medicine (the «reference medicine»EMA, ]) . According to the European Medicines Agency («EMA»), biosimilar medicines have become major therapeutic options, because they improve patient access […]

The Corporate Transparency Act (CTA)

Before 2024, there was no uniform federal procedure in the United States for reporting beneficial ownership. As we step into 2024, the Corporate Transparency Act (CTA) comes into effect, requiring a wide range of businesses to disclose their beneficial ownership details to the Financial Crimes Enforcement Network (FinCEN), a division of the U.S. Department of […]

DELSOL Avocats advised Maison Worms on the financing of AZmed

AZmed, a publisher of AI-based diagnostic software for radiologists, has raised 15 million Euros in a Series A round including the family office Maison Worms, Techstars and Tempact Ventures. This fundraising will enable the medtech to accelerate its international development and to use its artificial intelligence software to help radiologists and emergency doctors identify fractures. […]

Documents provided to French employees must be written in French

«Every man has two countries: his own and France.» – John F. Kennedy said that to Charles De Gaulle in 1961 while he was in Paris. This is particularly accurate when it comes to employment law. Indeed, Article L. 1321-6 of the French Labor Code provides that any document containing employee obligations or that is […]

DELSOL Avocats advised Plastic Omnium on the financing of Greenerwave

Greenerwave, European leader in electromagnetic wave control technologies, has raised 15 million Euros in a Series A round including the fund Innovation Défense (managed by Bpifrance), Safran Corporate Ventures, Intelsat, BNP Paribas Développement and Plastic Omnium. This fundraising will enable Greenerwave to increase its workforce, which already includes 85 associates, and to accelerate the development […]

DELSOL Avocats advised the management of IKV TRIBOLOGIE IKVT on its sale to QUAKER HOUGHTON

The American group QUAKER HOUGHTON, world leader in industrial process fluids, has acquired IKV TRIBOLOGIE IKVT and its subsidiaries. IKVT specializes in high-performance lubricants and greases that are primarily used in the automotive, aerospace, electronics, and other industrial markets and will be part of the QUAKER HOUGHTON’s EMEA segment. In the context of this transaction, […]

Arbitration in post-acquisition disputes

Share and asset acquisitions can give rise to a series of post-transaction disputes, including claims with regard to alleged breaches in representations and warranties, earn-out provisions, post-closing purchase price adjustments and non-compete provisions. Arbitration is increasingly used to resolve such disputes and arbitration clauses are frequently included in acquisition agreements. This is particularly the case […]

DELSOL Avocats supported Bpifrance in the reorganization of Manudo group’s equity capital

Manudo group, French leader in high-frequency and thermal welding for industry and in the medical field, is continuing its development with a convertible bond issue from Bpifancre and BNP Paribas Développement. Created in 1958, Manudo group employs 400 people and achieves a turnover of nearly 20 million Euros. Bpifrance, a public investment bank, participated in […]